An article in the Economic Times reports that clinical trials in India and other third world countries for drugs under process of development in the U.S have raised some ethical questions.
The other question is whether these drugs would be really made available in these countries.
Dr. Marcia Angell states that it's all about dollars and cents. Drugs against infectious diseases were most likely to be tested in the developing world followed by heart,allergy and arthritis medications. Vulnerable people in vulnerable countries are being used as drug laboratories.
The bottom line is what has been stated by M. Nabeel Ghayur who worked in drug development in Pakistan. According to him, people actually have blind trust in their doctor in South Asia. There is absolutely no awareness about what drug development was and how clinical trials are carried out!
This is a sad story!
The other question is whether these drugs would be really made available in these countries.
Dr. Marcia Angell states that it's all about dollars and cents. Drugs against infectious diseases were most likely to be tested in the developing world followed by heart,allergy and arthritis medications. Vulnerable people in vulnerable countries are being used as drug laboratories.
The bottom line is what has been stated by M. Nabeel Ghayur who worked in drug development in Pakistan. According to him, people actually have blind trust in their doctor in South Asia. There is absolutely no awareness about what drug development was and how clinical trials are carried out!
This is a sad story!
No comments:
Post a Comment